rs760261757
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_015404.4(WHRN):c.35C>T(p.Ser12Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000245 in 1,347,386 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S12W) has been classified as Uncertain significance.
Frequency
Consequence
NM_015404.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WHRN | NM_015404.4 | c.35C>T | p.Ser12Leu | missense_variant | 1/12 | ENST00000362057.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WHRN | ENST00000362057.4 | c.35C>T | p.Ser12Leu | missense_variant | 1/12 | 1 | NM_015404.4 | P1 | |
WHRN | ENST00000374057.3 | c.35C>T | p.Ser12Leu | missense_variant | 1/2 | 2 | |||
WHRN | ENST00000673697.1 | c.35C>T | p.Ser12Leu | missense_variant | 2/2 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD3 exomes AF: 0.0000324 AC: 3AN: 92478Hom.: 0 AF XY: 0.0000192 AC XY: 1AN XY: 52084
GnomAD4 exome AF: 0.0000245 AC: 33AN: 1347386Hom.: 0 Cov.: 34 AF XY: 0.0000301 AC XY: 20AN XY: 664450
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
not provided Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Aug 08, 2022 | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 12 of the WHRN protein (p.Ser12Leu). This variant is present in population databases (rs760261757, gnomAD 0.006%). This variant has not been reported in the literature in individuals affected with WHRN-related conditions. ClinVar contains an entry for this variant (Variation ID: 228564). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Tolerated"; PolyPhen-2: "Possibly Damaging"; Align-GVGD: "Class C0"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Sep 06, 2016 | The S12L variant in the DFNB31 gene has not been reported previously as a pathogenic variant, nor as a benign variant, to our knowledge. Sufficient data from control individuals in the NHLBI Exome Sequencing Project data set were not available to assess whether the S12L variant may be a common benign variant in the general population. The S12L variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Therefore, we interpret S12L as a variant of uncertain significance. - |
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Jul 06, 2015 | The p.Ser12Leu variant in DFNB31 has not been previously reported in individuals with hearing loss or Usher syndrome. Data from large population studies is insu fficient to assess the frequency of this variant. Computational prediction tools and conservation analysis do not provide strong support for or against an impac t to the protein. In summary, the clinical significance of the p.Ser12Leu varian t is uncertain. - |
Usher syndrome type 2D;C1846839:Autosomal recessive nonsyndromic hearing loss 31 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Feb 16, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at